Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas

American Journal of Clinical Pathology

Volumn 130, Issue 1, 2008, Pages 50-57

  Völker, Hans Ullrich ^a   Hagemann, Carsten ^a   Coy, Johannes ^a   Wittig, Rainer ^a   Sommer, Stephanie ^b   Stojic, Jelena ^a   Haubitz, Imme ^a   Vince, Giles Hamilton ^a   Kämmerer, Ulrike ^a   Monoranu, Camelia Maria ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Akt; Glioblastoma; Glioma; TKTL1; Transketolase; Transketolase like 1

Indexed keywords

PROTEIN KINASE B; TRANSKETOLASE; TRANSKETOLASE 1;

ARTICLE; ASTROCYTIC GLIOMA; CANCER CLASSIFICATION; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; WESTERN BLOTTING;

ASTROCYTOMA; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; TRANSKETOLASE; UP-REGULATION;

EID: 48249104383     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/6H9844AMMET82DBJ     Document Type: Article

References (34)

1. Wong ML, Kaye AH, Hovens CM. Targeting malignant glioma survival signalling to improve clinical outcomes. J Clin Neurosci. 2007;14:301-308.
2. Mischel PS, Cloughesy TF. Targeted molecular therapy of GBM. Brain Pathol. 2003;13:52-61.
3. Mérida I, Avila-Flores A. Tumor metabolism: new opportunities for cancer therapy. Clin Transl Oncol. 2006;8:711-716.
4. Jin S, DiPaola RS, Mathew R, et al. Metabolic catastrophe as a means to cancer cell death. J Cell Sci. 2007;120:379-383.
5. Warburg O, Posener K, Negelein E. Über den Stoffwechsel der Carcinomzelle. Biochem Z. 1924;152:309-344.
6. Schenk G, Duggleby RG, Nixon PF. Properties and functions of the thiamin diphosphate dependent enzyme transketolase. Int J Biochem Cell Biol. 1998;30:1297-1318.
7. Coy JF, Dressler D, Wilde J, et al. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab. 2005;51:257-273.
8. Langbein S, Zerilli M, Zur Hausen A, et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer. 2006;94:578-585.
9. Staiger WI, Coy JF, Grobholz R, et al. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer. Oncol Rep. 2006;16:657-661.
10. Krockenberger M, Honig A, Rieger L, et al. Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases. Int J Gynecol Cancer. 2007;17:101-106.
11. Volker HU, Scheich M, Schmausser B, et al. Overexpression of transketolase TKTL1 is associated with shorter survival in laryngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol. 2007;264:1431-1436.
12. Hu LH, Yang JH, Zhang DT, et al. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs. 2007;18:427-433.
13. Foldi M, Stickeler E, Bau L, et al. Transketolase protein TKTL1 overexpression: a potential biomarker and therapeutic target in breast cancer. Oncol Rep. 2007;17:841-845.
14. Riemenschneider MJ, Betensky RA, Pasedag SM, et al. AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling. Cancer Res. 2006;66:5618-5623.
15. Coloff JL, Rathmell JC. Metabolic regulation of Akt: roles reversed. J Cell Biol. 2006;175:845-847.
16. Elstrom RL, Bauer DE, Buzzai M, et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004;64:3892-3899.
17. Louis DN, Ohgaki H, Wiestler OD, et al, eds. WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC Press; 2007.
18. Stojic J, Hagemann C, Haas S, et al. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res. 2008;60:40-49.
19. Buzzai M, Bauer DE, Jones RG, et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene. 2005;24:4165-4173.
20. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891-899.
21. Boros LG, Bassilian S, Lim S, et al. Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: a new mechanism of controlling tumor growth. Pancreas. 2001;22:1-7.
22. Rajendran JG, Mankoff DA, O'Sullivan F, et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res. 2004;10:2245-2252.
23. Pardo FS, Aronen HJ, Fitzek M, et al. Correlation of FDG-PET interpretation with survival in a cohort of glioma patients. Anticancer Res. 2004;24:2359-2365.
24. Jelluma N, Yang X, Stokoe D, et al. Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes. Mol Cancer Res. 2006;4:319-330.
25. Stern R, Shuster S, Neudecker BA, et al. Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp Cell Res. 2002;276:24-31.
26. Fischer K, Hoffmann P, Voelkl S, et al. Inhibitory effect of tumor cell derived lactic acid on human T cells. Blood. 2007;109:3812-3819.
27. Schlegel J, Piontek G, Mennel HD. Activation of the antiapoptotic Akt/protein kinase B pathway in human malignant gliomas in vivo. Anticancer Res. 2002;22:2837-2840.
28. Knobbe CB, Reifenberger G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-39-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol. 2003;13:507-518.
29. Lord-Fontaine S, Averill-Bates DA. Heat shock inactivates cellular antioxidant defenses against hydrogen peroxide: protection by glucose. Free Radic Biol Med. 2002;32:752-765.
30. Zhang S, Yang JH, Guo CK, et al. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells. Cancer Lett. 2007;253:108-114.
31. 1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS Lett. 1999;456:113-118.
32. Comin-Anduix B, Boren J, Martinez S, et al. The effect of thiamine supplementation on tumour proliferation: a metabolic control analysis study. Eur J Biochem. 2001;268:4177-4182.
33. Xu RH, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005;65:613-621.
34. Ramos-Montoya A, Lee WN, Bassilian S, et al. Pentose phosphate cycle oxidative and nonoxidative balance: a new vulnerable target for overcoming drug resistance in cancer. Int J Cancer. 2006;119:2733-2741.